⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVCR News
NovoCure Limited Ordinary Shares
NovoCure Limited (NVCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NVCR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
accessnewswire.com
NVCR
Novocure to Report Second Quarter 2026 Financial Results
businesswire.com
NVCR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
globenewswire.com
NVCR
Bronstein, Gewirtz & Grossman, LLC Is Investigating NovoCure Limited (NVCR) And Encourages Investors to Connect
accessnewswire.com
NVCR
Form 8-K
sec.gov
NVCR
Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
businesswire.com
NVCR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
accessnewswire.com
NVCR
Bronstein, Gewirtz & Grossman, LLC Encourages NovoCure Limited (NVCR) Stockholders to Inquire about Securities Investigation
accessnewswire.com
NVCR
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NovoCure Limited (NVCR) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
NVCR